Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Tristan Manalac, Yesterday
While antibody titres against SARS-CoV-2 wane with time, the immune system is capable of producing memory B-cells that can last for at least 6 months after infection, suggesting that the body will be able to protect itself in the case of re-exposure, according to a new study.
Jairia Dela Cruz, 5 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.

SARS-CoV-2 does not transmit from mother to child during pregnancy

Pearl Toh
25 Dec 2020

A new study finds no evidence of vertical transmissions of SARS-CoV-2 from mother to child during pregnancy, but there appears to be limited transplacental transfer of anti-SARS-CoV-2 antibodies to the neonates in utero.

“[The] reduced transplacental transfer of anti–SARS-CoV-2 antibodies may leave neonates at risk for infection,” the researchers pointed out.

“Our finding of compromised mother-to-baby transfer of SARS-CoV-2-specific antibodies in third trimester infections has implications for maternal vaccine administration,” said lead author Dr Andrea Edlow from Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, US.

In the prospective cohort study involving 127 pregnant women, 64 were tested positive for SARS-CoV-2 (mean age 31.6 years), based on nasopharyngeal swab RT-PCR. Among the infected women, 36 percent were asymptomatic and 34 percent had mild disease. [JAMA Netw Open 2020;doi:10.1001/jamanetworkopen.2020.30455]

When analysing for viral load in biofluids, the researchers did not detect any viraemia in maternal or cord blood – indicating no evidence of vertical transmission of SARS-CoV-2 infection from mother to child and no placental infection.

For quantification of SARS-CoV-2 antibodies, one out of 77 neonates analysed showed immunoglobuilin M antibodies to the viral nucleocapsid in their cord blood, although viral RNA was not detected in any placenta. The antibodies, as the authors believed, could be from the mothers as RNA analysis showed none of the infants had been infected.

In fact, when analysing for antibodies among the 37 infected women, anti-nucleocapsid antibodies were present in 70 percent of them and anti–receptor binding domain immunoglobin G was found in 65 percent.

As a control comparison for mother-to-neonate transfer of antibodies, the researchers also measured transfer of anti-influenza antibodies in the mother-neonate pairs. Indeed, transfer of antibodies against SARS-CoV-2 was significantly lower than that of anti-influenza haemagglutinin A antibodies from mothers to neonates (mean cord-to-maternal ratios: 0.72 for anti-receptor binding domain immunoglobin G and 0.74 for anti-nucleocapsid, vs 1.44 for anti-influenza; p<0.001).

As transplacental transfer of antibodies from mothers to neonates is usually highest in the third trimester, Edlow said the significantly limited transfer of SARS-CoV-2 antibodies relative to influenza antibodies was unexpected.

“[The study] highlights that pregnant women are a key population to consider in vaccine rollouts. It also raises questions regarding the optimal timing of vaccine administration to best support maternal and newborn immunity,” said Edlow.

“Although it is not known whether the inefficient transplacental transfer of antibodies observed will also extend to antibodies elicited by future SARS-CoV-2 vaccines, it underscores the susceptibility of infants, particularly since it is unlikely that young infants will be eligible for SARS-CoV-2 vaccination,” wrote Drs Denise Jamieson and Sonja Rasmussen from Emory University School of Medicine in Atlanta, Georgia and University of Florida College of Medicine, Gainesville, Florida, US, in a linked commentary. [JAMA Netw Open 2020;doi:10.1001/jamanetworkopen.2020.30564]

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Tristan Manalac, Yesterday
While antibody titres against SARS-CoV-2 wane with time, the immune system is capable of producing memory B-cells that can last for at least 6 months after infection, suggesting that the body will be able to protect itself in the case of re-exposure, according to a new study.
Jairia Dela Cruz, 5 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.